Grufity logoGrufity logo

AGL

18.06USD+0.50(+2.85%)Market Closed

agilon health, inc.

Market Summary

USD18.06+0.50Market Closed
2.85%

AGL Alerts

AGL Stock Price

RSI Chart

Valuation

Market Cap

8.3B

Price/Earnings

-73.83

Price/Sales

3.68

Price/Cashflow

-54.56

MarketCap/EBT

-72.66

Price/Sales

Profitability

EBT Margin

-5.07%

Return on Equity

-10.14%

Return on Assets

-6.08%

Fundamentals

Revenue

Revenue (TTM)

2.2B

Revenue Y/Y

34.31%

Revenue Q/Q

2.55%

Earnings

Earnings (TTM)

-112.0M

Earnings Y/Y

93.09%

Earnings Q/Q

-1.8K%

Price Action

52 Week Range

28.36
(Low)(High)

Last 7 days

9.9%

Last 30 days

-8.9%

Last 90 days

-14.3%

Trailing 12 Months

-19.7%

Financial Health

Current Ratio

2.65

Debt/Equity

0.04

Debt/Cashflow

-3.11

Investor Care

Shares Dilution (1Y)

5.13%

Financials for agilon health

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Revenue8.3%2,2452,0741,8341,6921,546
Operating Expenses-4.3%2,3502,4562,2282,0781,906
  S&GA Expenses-36.2%468734456436432
Earnings Before Taxes70.8%-113.79-390.22-404.60-386.16-361.69
Net Income71.3%-111.98-390.18-406.49-373.98-349.96
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Assets-0.8%1,8411,8551,5861,6851,702
  Current Assets-1.6%1,6011,6281,3671,4531,480
    Cash Equivalents-34.6%6691,0221,0401,0821,109
  Net PPE26.2%1613965
  Goodwill0%4242424242
Liabilities-0.9%737744495558551
  Current Liabilities-0.9%605610357423412
  Long Term Debt-49----
    LT Debt, Current0%55554
    LT Debt, Non Current-2.9%4142434546
Shareholder's Equity-0.7%1,1041,1121,0921,1281,150
  Retained Earnings-2.2%-977.10-956.45-957.68-900.96-865.11
  Additional Paid-In Capital0.6%2,0762,0642,0462,0252,012
Accumulated Depreciation-12.4%89898
Shares Outstanding0.6%408406400392391
Minority Interest-21.9%-0.46-0.37-0.30-0.28-0.17
Float-6,600----
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Cashflow From Operations-16.1%-151.54-130.56-148.16-112.60-97.82
  Share Based Compensation-90.9%27295292290279
Cashflow From Investing-254.0%-319.65-90.30-90.51-64.63-51.92
Cashflow From Financing-97.4%291,1381,1541,1431,136
  Buy Backs100.0%0-0.17
* denotes actual numbers (not divided by Millions)

Risks

What is the probability of a big loss on AGL?

84.7%


Probability that agilon health stock will be more than 20% underwater in next one year

74.1%


Probability that agilon health stock will be more than 30% underwater in next one year.

71.8%


Probability that agilon health stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does AGL drawdown profile look like?

Y-axis is the maximum loss one would have experienced if agilon health was unfortunately bought at previous high price.

Returns

Cumulative Returns on AGL

Which funds bought or sold AGL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-21
Parallax Volatility Advisers, L.P.
-
-
406,000
731,000
-%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
305,000
5,863,000
0.01%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
ADDED
4,059.28
744,000
761,000
-%
2022-11-16
Neo Ivy Capital Management
NEW
-
-
-
-%
2022-11-15
ALLIANCEBERNSTEIN L.P.
REDUCED
-2.91
101,000
2,530,000
-%
2022-11-15
ALGERT GLOBAL LLC
ADDED
375.83
2,071,000
2,576,000
0.16%
2022-11-15
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO
UNCHANGED
-
746,000
10,980,000
0.06%
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%
2022-11-15
STATE STREET CORP
ADDED
28.55
19,071,000
69,368,000
-%
2022-11-15
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
ADDED
1.84
188,000
2,222,000
0.01%

1–10 of 43

Latest Funds Activity

Are funds buying AGL calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own AGL

agilon health News

MZP News

Analysis of agilon health inc. (AGL)’s performance, earnings and valuation.42 hours ago

AGL Fair Value

Recent SEC filings of agilon health

View All Filings
Date Filed Form Type Document
Nov 22, 2022
4
Insider Trading
Nov 18, 2022
4
Insider Trading
Nov 18, 2022
4
Insider Trading
Nov 03, 2022
8-K
Current Report
Nov 03, 2022
4
Insider Trading
Nov 03, 2022
10-Q
Quarterly Report
Oct 21, 2022
4
Insider Trading
Oct 21, 2022
4/A
Insider Trading
Oct 18, 2022
4
Insider Trading
Oct 05, 2022
3
Insider Trading

Latest Insider Trading transactions for AGL

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-18
Sell Steven
BOUGHT
49,704.6
17.1395
2,900
CEO & President
2022-11-17
Kornitzer Benjamin
SOLD
-94,055
17.4305
-5,396
Chief Med. & Quality Officer
2022-11-17
Shaker Benjamin
ACQUIRED
56,250
3
18,750
Chief Markets Officer
2022-11-17
Shaker Benjamin
SOLD
-321,956
17.171
-18,750
Chief Markets Officer
2022-11-17
Kornitzer Benjamin
ACQUIRED
24,228
4.49
5,396
Chief Med. & Quality Officer
2022-11-16
Kornitzer Benjamin
ACQUIRED
24,228
4.49
5,396
Chief Med. & Quality Officer
2022-11-16
Shaker Benjamin
ACQUIRED
56,250
3
18,750
Chief Markets Officer
2022-11-16
Kornitzer Benjamin
SOLD
-99,918.8
18.5172
-5,396
Chief Med. & Quality Officer
2022-11-16
Shaker Benjamin
SOLD
-343,009
18.2938
-18,750
Chief Markets Officer
2022-11-02
Kornitzer Benjamin
SOLD
-105,407
19.5343
-5,396
Chief Med. & Quality Officer

1–10 of 50

Steven J. Sell
650
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

AGL Income Statement

2022-09-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:    
Total revenues$ 694,858$ 458,613$ 2,018,437$ 1,370,673
Expenses:    
Medical services expense618,287414,2021,771,6351,217,039
Other medical expenses50,65929,454144,51286,809
General and administrative (including noncash stock-based compensation expense of $7,907, $11,960, $18,430, and $287,980, respectively)51,98046,643143,738401,981
Depreciation and amortization3,4503,9159,86510,923
Total expenses724,376494,2142,069,7501,716,752
Income (loss) from operations(29,518)(35,601)(51,313)(346,079)
Other income (expense):    
Other income (expense), net574(269)9,8404,034
Gain (loss) on lease terminations00(5,458)0
Interest expense(1,000)(867)(2,816)(5,306)
Income (loss) before income taxes(29,944)(36,737)(49,747)(347,351)
Income tax benefit (expense)(559)(256)(1,068)(707)
Income (loss) from continuing operations(30,503)(36,993)(50,815)(348,058)
Discontinued operations:    
Income (loss) before income taxes(224)1,117526(1,781)
Income tax benefit (expense)(12)(82)(26)(211)
Total discontinued operations(236)1,035500(1,992)
Net income (loss)(30,739)(35,958)(50,315)(350,050)
Noncontrolling interests' share in (earnings) loss71115228284
Net income (loss) attributable to common shares$ (30,668)$ (35,843)$ (50,087)$ (349,766)
Net income (loss) per common share, basic and diluted    
Income (Loss) from Continuing Operations, Per Basic Share$ (0.07)$ (0.09)$ (0.12)$ (0.95)
Income (Loss) from Continuing Operations, Per Diluted Share(0.07)(0.09)(0.12)(0.95)
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share000(0.01)
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share$ 0$ 0$ 0$ (0.01)
Weighted average shares outstanding - basic411,065391,229406,823365,018
Weighted average shares outstanding - diluted411,065391,229406,823365,018
Medical Services Revenue    
Revenues:    
Total revenues$ 693,934$ 457,646$ 2,015,541$ 1,367,736
Other Operating Revenue    
Revenues:    
Total revenues$ 924$ 967$ 2,896$ 2,937

AGL Balance Sheet

2022-09-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 551,287$ 1,040,039
Restricted cash and equivalents[1]13,19214,781
Marketable securities407,993
Receivables, net637,731293,407
Prepaid expenses and other current assets, net24,06718,968
Total current assets1,634,2701,367,195
Property and equipment, net17,9409,161
Intangible assets, net60,60255,398
Goodwill41,54041,540
Other assets, net116,083112,958
Total assets1,870,4351,586,252
Current liabilities:  
Medical claims and related payables490,840239,014
Accounts payable and accrued expenses162,386112,946
Current portion of long-term debt5,0005,000
Total current liabilities658,226356,960
Long-term debt, net of current portion39,71343,401
Other liabilities87,20794,295
Total liabilities785,146494,656
Commitments and contingencies
Stockholders' equity (deficit):  
Common stock, $0.01 par value: 2,000,000 shares authorized; 408,204 and 400,095 shares issued and outstanding, respectively4,1174,001
Additional paid-in capital2,094,5622,045,572
Accumulated deficit(1,007,764)(957,677)
Accumulated other comprehensive income (loss)(5,098)0
Total agilon health, inc. stockholders' equity (deficit)1,085,8171,091,896
Noncontrolling interests(528)(300)
Total stockholders’ equity (deficit)1,085,2891,091,596
Total liabilities and stockholders' equity (deficit)$ 1,870,435$ 1,586,252
[1]Restricted cash and equivalents primarily consist of amounts used as collateral to secure letters of credit that the Company is required to maintain pursuant to contracts with payors.